Latest New Zealand News

McPherson's Limited reported a 3.9% revenue decline in FY25 driven by exiting lower-margin brands, while core brands grew 1.9%. The company posted a statutory net loss of $15 million, weighed down by significant impairments as it completes a major operating model transformation.

McPherson’s Limited reported a 3.9% revenue decline in FY25 due to shedding non-strategic brands, while its core health and beauty brands grew modestly. The company’s transition to a wholesaler and third-party logistics model marks a pivotal shift aimed at long-term growth despite a widened net loss.

Domino’s Pizza Enterprises reported a modest dip in FY25 sales and earnings amid a strategic reset focused on cost efficiency and franchisee support. The company aims to rebuild momentum through targeted reinvestment and operational simplification.

Domino’s Pizza Enterprises reported flat network sales and a modest decline in earnings for FY25, unveiling a comprehensive strategic reset focused on cost reduction, franchisee profitability, and market-specific turnarounds.

Sigma Healthcare reports a robust FY25 performance post-merger with Chemist Warehouse Group, delivering strong revenue growth and upgraded synergy targets. The company signals continued expansion and efficiency gains heading into FY26.

Sigma Healthcare reports a robust 41% rise in EBIT following its merger with Chemist Warehouse, upgrading synergy targets and expanding its retail footprint internationally.

Sigma Healthcare has completed a reverse acquisition merger with Chemist Warehouse, reporting $6 billion in revenue and declaring a fully franked dividend. The merger reshapes Australia’s pharmacy landscape with ambitious synergy targets and operational shifts.

Flight Centre Travel Group Limited has announced a fully franked ordinary dividend of AUD 0.29 per share for the financial year ending June 30, 2025, with flexible multi-currency payment options for shareholders.

Atturra Limited reported a robust 24% increase in revenue and underlying EBITDA for FY25, driven by six strategic acquisitions and expanded government contracts. Despite a slight dip in net profit, the company is poised for further growth with a 10% share buyback and a strong focus on AI and enterprise solutions.

ParagonCare Limited reported a solid FY25 with $3.6 billion in revenue and $95.2 million underlying EBITDA, marking progress in its integration and growth strategy across Asia Pacific. The company is poised for further profitability improvements and expansion in FY26.

Paragon Care Limited reported a robust 22% increase in revenue to $3.61 billion for FY25, driven by organic growth and key acquisitions including CH2 Holdings and Oborne Health Supplies. The company also refinanced its debt facilities and expanded into the dental market post-year-end.

Cash Converters International Limited reported a robust 41% increase in net profit for FY2025, driven by strategic franchise acquisitions and a shift in loan product mix. The company declared a fully franked final dividend and maintains a strong balance sheet as it navigates evolving regulatory and market conditions.